Integer (NYSE:ITGR) is scheduled to announce its earnings results before the market opens on Thursday, October 31st. Analysts expect the company to announce earnings of $1.06 per share for the quarter. Integer has set its FY19 guidance at $4.25-4.45 EPS.Investors that are interested in participating in the company’s conference call can do so using this link.
Integer (NYSE:ITGR) last issued its earnings results on Thursday, August 1st. The medical equipment provider reported $1.23 EPS for the quarter, topping the consensus estimate of $1.06 by $0.17. The firm had revenue of $314.20 million during the quarter, compared to analysts’ expectations of $318.50 million. Integer had a return on equity of 13.31% and a net margin of 15.73%. Integer’s quarterly revenue was down .1% compared to the same quarter last year. During the same period last year, the business earned $1.06 earnings per share. On average, analysts expect Integer to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Shares of ITGR stock opened at $76.90 on Tuesday. The stock has a market cap of $2.48 billion, a P/E ratio of 20.24 and a beta of 1.05. Integer has a one year low of $67.72 and a one year high of $92.61. The stock has a fifty day moving average price of $75.79 and a 200 day moving average price of $76.64. The company has a debt-to-equity ratio of 0.78, a current ratio of 2.42 and a quick ratio of 1.41.
Several research analysts recently commented on ITGR shares. Northcoast Research reaffirmed a “buy” rating on shares of Integer in a research report on Friday, August 2nd. ValuEngine cut Integer from a “hold” rating to a “sell” rating in a research report on Friday, August 2nd. One analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. Integer has a consensus rating of “Hold” and a consensus price target of $72.57.
In other Integer news, Director Jean M. Hobby sold 6,000 shares of Integer stock in a transaction on Monday, August 5th. The stock was sold at an average price of $80.19, for a total transaction of $481,140.00. Following the completion of the transaction, the director now directly owns 15,475 shares of the company’s stock, valued at $1,240,940.25. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.24% of the stock is currently owned by company insiders.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Further Reading: Why does a company issue an IPO?
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.